Thank You for an Incredible Patient Forum.
"Collaborating for a Cure" is an online, half-day forum hosted by the Scleroderma Research Foundation that anyone can attend for FREE. This year, "Collaborating for a Cure" was held on June 3rd at 9:00 am PDT/12:00 pm EDT as part of our efforts for Scleroderma Awareness Month. Don't miss these educational sessions on symptom management, new developments in research, and your role in finding a cure for scleroderma:Informative sessions presented by leaders in the field of scleroderma research and medicine
Live Q&A following each presentation
Interactive games and activities to win prizes
Interested in becoming a sponsor for next year's forum? Contact Kate Ceredona, SRF Director of Philanthropy, at kate@sclerodermaresearch.org
Get to know everyone who's helping us bring the most up-to-date information directly to you.
Can't wait for the next forum? Check out our sessions from previous years to start learning more about scleroderma now.
Share Your Story: Post a video on social media saying “scleroderma” and why awareness is important to you. Check out our social media toolkit for more ideas!
Start Conversations: Talk to your friends, family, and colleagues about scleroderma. Every conversation counts.
Add a Profile Frame: Show your support proudly by updating your social media profile picture with our special #SayScleroderma profile frame
Spread the Word: Share our #SayScleroderma social media posts and tag us (@srfcure) to help us reach even more people.
Or, send us an email at info@srfcure.org and let us know how you’ve made an impact. You can also give us a call at 800.441.CURE (2873).
The mission of the Scleroderma Research Foundation (SRF) is to fund and facilitate the most promising, highest quality research aimed at improved therapies and, ultimately, a cure for scleroderma.
The Scleroderma Research Foundation (SRF) was founded in 1987 by Sharon Monsky, an entrepreneur, businesswoman, and person with scleroderma. Guided by Sharon’s passion for a cure, we have become the largest nonprofit investor in scleroderma research in the United States.
The SRF research program seeks to understand scleroderma by facilitating collaboration among the world’s top scientists and medical institutions.
CONQUEST is a global, perpetual, platform clinical trial developed by the Scleroderma Research Foundation in coordination with partner biopharmaceutical companies. Its goal? To accelerate the clinical development of potential therapies for scleroderma.
More specifically, CONQUEST is designed to identify potential treatments that should progress from phase 2b to phase 3 clinical trials.
CONQUEST is based on a model first created over a decade ago to accelerate oncology drug development. This international, multicenter, randomized, double-blind, placebo-controlled, phase 2b platform clinical trial is the first of its kind in rare autoimmune diseases.
Information on common complications and treatments, participating in research, and more
A world-class team, dedicated to finding improved treatments and, ultimately, a cure
A special feature on the SRF, aired on The Balancing Act on the Lifetime network earlier this year
How one of the world's most beloved comedians became a champion for everyone affected by scleroderma
Join our mailing list to get the Scleroderma Research Foundation's monthly eNews.